Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04142385

Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men

Incidence of Human Immunodeficiency Virus (HIV) Among Indian Men Who Have Sex With Men (MSM)

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
AIDS Malignancy Consortium · Network
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research trial studies the incidence of human immunodeficiency virus (HIV) infection in screening Indian men who have sex with men (MSM). Gathering health information over time from Indian MSM may help doctors determine how many Indian MSM develop new cases of HIV infection.

Detailed description

PRIMARY OBJECTIVES: I. To determine the one-year incidence of HIV among high-risk MSM in India. SECONDARY OBJECTIVES: I. To test the feasibility and acceptability of recruiting a sample of 150 high-risk HIV-uninfected MSM using respondent-driven sampling (RDS) and following them every six months for one year. II. To produce preliminary descriptive data on the prevalence and incidence of human papillomavirus (HPV) infection and HPV-associated disease and sexually transmitted infections (STIs) other than HPV in HIV-seronegative MSM in India. III. To produce preliminary descriptive data on sexual risk behaviors with men and women, as well as data on other potential confounders. OUTLINE: Participants receive a questionnaire, undergo a targeted physical and anal clinical exam, undergo blood collection and urethral swab for STIs, and a penile skin cell and anal swab for cytology and HPV deoxyribonucleic acid (DNA) at months 0, 6, and 12. Participants also undergo high-resolution anoscopy (HRA) and penile clinical exam at month 12.

Conditions

Interventions

TypeNameDescription
OTHERCytology Specimen Collection ProcedureUndergo blood, urethral swab, penile skin cell, and anal swab collection
OTHERLaboratory Biomarker AnalysisCorrelative studies
PROCEDUREMedical ExaminationUndergo anal and penile clinical exam
PROCEDUREPhysical ExaminationUndergo targeted physical exam
PROCEDUREProctoscopy with BiopsyUndergo HRA
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2027-04-30
Primary completion
2029-12-31
Completion
2031-12-31
First posted
2019-10-29
Last updated
2025-06-06

Locations

3 sites across 2 countries: United States, India

Source: ClinicalTrials.gov record NCT04142385. Inclusion in this directory is not an endorsement.